GLP-1-mediated delivery of the PPAR𝛼/𝛾 dual-agonist Tesaglitazar improves obesity and glucose metabolism in miceCarmelo Quarta, Timo D. Müller, Gustav Colldén et al.|Research Square|2021Cited by 0